Searching for prostate cancer by fully automated magnetic resonance imaging classification: deep learning versus non-deep learning.

Journal: Scientific reports
PMID:

Abstract

Prostate cancer (PCa) is a major cause of death since ancient time documented in Egyptian Ptolemaic mummy imaging. PCa detection is critical to personalized medicine and varies considerably under an MRI scan. 172 patients with 2,602 morphologic images (axial 2D T2-weighted imaging) of the prostate were obtained. A deep learning with deep convolutional neural network (DCNN) and a non-deep learning with SIFT image feature and bag-of-word (BoW), a representative method for image recognition and analysis, were used to distinguish pathologically confirmed PCa patients from prostate benign conditions (BCs) patients with prostatitis or prostate benign hyperplasia (BPH). In fully automated detection of PCa patients, deep learning had a statistically higher area under the receiver operating characteristics curve (AUC) than non-deep learning (P = 0.0007 < 0.001). The AUCs were 0.84 (95% CI 0.78-0.89) for deep learning method and 0.70 (95% CI 0.63-0.77) for non-deep learning method, respectively. Our results suggest that deep learning with DCNN is superior to non-deep learning with SIFT image feature and BoW model for fully automated PCa patients differentiation from prostate BCs patients. Our deep learning method is extensible to image modalities such as MR imaging, CT and PET of other organs.

Authors

  • Xinggang Wang
    Department of Radiology, Tongji Hospital, Huazhong University of Science and Technology, Jiefang Road 1095, 430030, Wuhan, China.
  • Wei Yang
    Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), Ministry of Education, School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Wenhua Road 103, Shenyang 110016, PR China. Electronic address: 421063202@qq.com.
  • Jeffrey Weinreb
    Department of Radiology and Biomedical Imaging, Yale University School of Medicine, New Haven, 208042, Connecticut, USA.
  • Juan Han
    Department of Maternal and Child and Adolescent & Department of Epidemiology and Biostatistics, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Hangkong Road 13, 430030, Wuhan, China.
  • Qiubai Li
    Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA, 02115, USA.
  • Xiangchuang Kong
    Department of Radiology, Union Hospital, Huazhong University of Science and Technology, Jiefang Road 1277, 430022, Wuhan, China.
  • Yongluan Yan
    School of Electronics Information and Communications, Huazhong University of Science and Technology, Luoyu Road 1037, Wuhan, Hubei, 430074, China.
  • Zan Ke
    Department of Radiology, Tongji Hospital, Huazhong University of Science and Technology, Jiefang Road 1095, 430030, Wuhan, China.
  • Bo Luo
    School of mechanical science and engineering, Huazhong University of Science and Technology, Luoyu Road 1037, 430074, Wuhan, China.
  • Tao Liu
    Institute of Urology and Nephrology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
  • Liang Wang
    Information Department, Dazhou Central Hospital, Dazhou 635000, China.